GHDX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Genomic Health Inc's quarterly cash and cash equivalents declined from Sep. 2013 ($39.8 Mil) to Dec. 2013 ($33.3 Mil) and declined from Dec. 2013 ($33.3 Mil) to Mar. 2014 ($28.2 Mil).
Genomic Health Inc's annual cash and cash equivalents declined from Dec. 2011 ($32.9 Mil) to Dec. 2012 ($18.0 Mil) but then increased from Dec. 2012 ($18.0 Mil) to Dec. 2013 ($33.3 Mil).
Cash and cash equivalents on banks book.
Genomic Health Inc Annual Data
Genomic Health Inc Quarterly Data